Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL: Safety Overview

Metric FOSAPREPITANT DIMEGLUMINE FOSINOPRIL
Total FAERS Reports 888 461
Deaths Reported 118 36
Death Rate 13.3% 7.8%
Hospitalizations 364 219
Average Patient Age 57.0 yrs 66.1 yrs
% Female Patients 50.1% 41.5%
FDA Approval Date Aug 20, 2020 Apr 20, 2005
Manufacturer Dr. Reddy's Laboratories Inc., Chartwell RX, LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued